Novartis to work with FDA on path forward for RLX030 for acute heart failure following Advisory Committee outcome
28 March 2014 | By Novartis
Advisory Committee members voted against RLX030 for the treatment of acute heart failure (AHF)...
List view / Grid view
News
EMA validates Gilead’s marketing application for Ledipasvir/Sofosbuvir fixed-dose combination tablet for Genotype 1 Chronic Hepatitis C infection
28 March 2014 | By Gilead Sciences
If approved, once-daily tablet would simplify therapy and eliminate need for Interferon and Ribavirin for Genotype 1 Hepatitis C patients in Europe...
Cancer Research UK drug launched in its first clinical trial
28 March 2014 | By Cancer Research Technology (CRT)
A new cancer drug, based on further development of a discovery originally made by Cancer Research UK, has entered a clinical trial to target a wide range of cancers.
Baxter announces plans to create two separate global healthcare companies
28 March 2014 | By Baxter International Inc.
Baxter International Inc. has announced plans to create two separate, independent global healthcare companies – one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products...
Where do you start when developing a new medicine?
27 March 2014 | By GlaxoSmithKline
Novel scientific collaboration to use genomics and big data to drive drug discovery...
Merck announces appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, who has served in the role since 2007
27 March 2014 | By Merck
Merck announced the appointment of Robert M. Davis as executive vice president and chief financial officer, effective April 23, 2014....
In a subanalysis, the benefits of eliquis® (apixaban) vs. Warfarin in reducing the risk of stroke in patients with nonvalvular atrial fibrillation were consistent, regardless of blood pressure control
27 March 2014 | By Bristol-Myers Squibb
Blood pressure control key factor in stroke risk...
TESCAN ORSAY HOLDING, a.s. and WITec GmbH launch the RISE Microscope for correlative Raman-SEM Imaging at Analytica 2014
27 March 2014 | By WITec
TESCAN ORSAY HOLDING, a.s. and WITec GmbH jointly launch RISE Microscopy at Analytica 2014...
EMA reorganisation: changes to handling of certain evaluation procedures to be introduced from 1 April 2014
26 March 2014 | By The European Medicines Agency
Handling of all other evaluation procedures to remain unchanged until further announcement later this year...
Pfizer achieves primary endpoint with Phase 3b top-line results of GENOTROPIN® in very young children born small for gestational age
26 March 2014 | By Pfizer
Pfizer Inc. announced the top-line results from a Phase 3B study evaluating the 24-month efficacy of GENOTROPIN®...
GSK receives European authorisation for once-weekly type 2 diabetes treatment, Eperzan®
26 March 2014 | By GlaxoSmithKline
GlaxoSmithKline plc announced that the European Commission has granted marketing authorisation for its once-weekly diabetes treatment, Eperzan® (albiglutide)...
AstraZeneca completes purchase of Sumitomo Chemical’s stake in AstraZeneca K.K.
26 March 2014 | By AstraZeneca
AstraZeneca today announced it has completed the purchase of Sumitomo Chemical’s remaining shares in AstraZeneca K.K...
New Asia Tube Cooler from Syrris enables extra low temperature flow reactions
26 March 2014 | By kdm communications
Syrris is pleased to announce the launch of the Asia Tube Cooler, the latest addition to the Company’s range of advanced flow chemistry products...
Cancer Research UK launches trial to fight cancer caused by a common virus
26 March 2014 | By Cancer Research UK
Cancer Research UK’s Drug Development Office has launched a trial of a vaccine to treat some forms of cancer caused by a common virus known as the Epstein Barr Virus...
Eliminate tedious sample preparation with laboratory automation from Tecan
25 March 2014 | By kdm communications
Tecan offers a wide range of laboratory automation solutions for mass spectrometry sample preparation, ensuring there is a system to meet your workflow and throughput needs...
